Greedy Trial Lawyer
Big Pharma & Lawyers In Race To Bottom With Wall-to-Wall TV Commercials
Category: Seeing Clearly Now
The legal profession has experienced a drop in public esteem for a number of years. More recently drug manufacturers have suffered the safe fate. There is a common denominator - advertising on mass media. PharmaGossip has the details.
Big Pharma's reputation - how low can it go?
Pharmaceutical firms need to make some drastic changes to the way they do business if they are to regain the public's trust and must be seen to be more interested in medicines than market share to avoid even more damage to their image, a leading industry observer has told PharmaTimes World News.Peter Claude, a USA-based partner at PricewaterhouseCoopers pharmaceutical and life sciences advisory services group, was speaking as the firm published a report, Recapturing the Vision which highlights the significant differences between the public's view of pharmaceutical companies and the industry's self perception.
Mr. Claude said that "it is difficult to comprehend how an industry that has saved so many lives should be held in such low public esteem," noting that "in the current climate of distrust, the public is questioning the industry's motives and practices from sales and marketing to pricing to drug development."
DTC [direct-to-consumer] advertising needs to be more serious and scientific. A change needs to be made in the way sales and marketing practices are carried out and the industry has focused for too long on the doctor rather than the patient.
This change can be achieved in a number of ways, Mr Claude explained, one of which is to improve the quality of direct-to-consumer advertising on TV and focusing on the serious scientific benefits of the drug.
The legal profession should read Recapturing the Vision before it drops below child molesters in the eyes of the public it is pounding with inane commercials.
Trackback Pings
TrackBack URL for this entry:
http://www.greedytriallawyer.com/admin/mt-tb.cgi/460